Literature DB >> 11329578

Internal anal sphincter achalasia: outcome after internal sphincter myectomy.

D De Caluwé1, A Yoneda, U Akl, P Puri.   

Abstract

BACKGROUND: Internal anal sphincter achalasia (IASA), also referred to as ultrashort segment Hirschsprung's disease (HD), is a clinical condition with presentation similar to HD, but with the presence of ganglion cells on rectal biopsy. The diagnosis of IASA is made on anorectal manometry, which shows the absence of rectosphincteric reflex on rectal balloon inflation. Altered intramuscular innervation has been reported in IASA. The purpose of this study was to review the outcome after internal sphincter myectomy in patients with IASA.
METHODS: Fifteen consecutive patients (age range, 2 years to 12 years) with IASA underwent posterior internal sphincter myectomy. All patients presented with severe constipation with or without soiling. The diagnosis of IASA was made by anorectal manometry. HD was excluded in these cases by the presence of ganglion cells and normal acetylcholinesterase activity on suction rectal biopsies. Internal sphincter (IS) specimens were examined using immunohistochemistry for the general neuronal marker PGP 9.5 and synapsin 1 (a presynaptic marker) and using general histochemistry for NADPH-diaphorase. All patients underwent follow-up for periods from 2 years to 6 years.
RESULTS: PGP 9.5, synapsin 1 and NADPH-diaphorase positive nerve fibers were either absent or markedly reduced in IASA specimens compared with controls, confirming previous reports of defective intramuscular innervation in IASA. At the time of follow-up, 7 patients have regular bowel motions and are not on any laxatives. Six patients have normal bowel habits but are on small doses of laxatives. One patient is able to stay clean with regular enema regimen. One patient required resection of dilated and redundant sigmoid colon and now has normal bowel habits with laxatives.
CONCLUSION: The majority of patients with internal anal sphincter achalasia can be treated successfully by internal sphincter myectomy. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11329578     DOI: 10.1053/jpsu.2001.22949

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  16 in total

1.  Hirschsprung's Disease.

Authors:  William M. Belknap
Journal:  Curr Treat Options Gastroenterol       Date:  2003-06

Review 2.  Enteric nervous system and developmental abnormalities in childhood.

Authors:  Thambipillai Sri Paran; Udo Rolle; Prem Puri
Journal:  Pediatr Surg Int       Date:  2006-12       Impact factor: 1.827

3.  Long-term outcome after internal sphincter myectomy for internal sphincter achalasia.

Authors:  M Heikkinen; H Lindahl; R J Rintala
Journal:  Pediatr Surg Int       Date:  2004-12-23       Impact factor: 1.827

Review 4.  Interstitial cells of Cajal in the normal gut and in intestinal motility disorders of childhood.

Authors:  Udo Rolle; Anna Piaseczna-Piotrowska; Prem Puri
Journal:  Pediatr Surg Int       Date:  2007-12       Impact factor: 1.827

Review 5.  Classification and diagnostic criteria of variants of Hirschsprung's disease.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

6.  Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction.

Authors:  Katy Irani; Leonel Rodriguez; Daniel P Doody; Allan M Goldstein
Journal:  Pediatr Surg Int       Date:  2008-04-29       Impact factor: 1.827

7.  Internal anal sphincter achalasia: data from a nationwide survey of allied disorders of Hirschsprung's disease in Japan.

Authors:  Satoshi Obata; Suguru Fukahori; Minoru Yagi; Makoto Suzuki; Shigeru Ueno; Kosuke Ushijima; Tomoaki Taguchi
Journal:  Surg Today       Date:  2017-04-28       Impact factor: 2.549

8.  Comparison of posterior internal anal sphincter myectomy and intrasphincteric botulinum toxin injection for treatment of internal anal sphincter achalasia: a meta-analysis.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2012-08       Impact factor: 1.827

9.  Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children.

Authors:  Ricardo A Arbizu; Leonel Rodriguez
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

10.  Childhood constipation: evaluation and management.

Authors:  Dinesh S Pashankar
Journal:  Clin Colon Rectal Surg       Date:  2005-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.